Kim, S. Et Al. 2005. Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer. CANCER RESEARCH , vol.65, no.9 , 3707-3715.

Kim, S., Uehara, H., Yazici, S., He, J., Langley, R., Mathew, P., ... Fan, D.(2005). Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer. CANCER RESEARCH , vol.65, no.9, 3707-3715.

Kim, SJ Et Al. "Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer," CANCER RESEARCH , vol.65, no.9, 3707-3715, 2005

Kim, SJ Et Al. "Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer." CANCER RESEARCH , vol.65, no.9, pp.3707-3715, 2005

Kim, S. Et Al. (2005) . "Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer." CANCER RESEARCH , vol.65, no.9, pp.3707-3715.

@article{article, author={SJ Kim Et Al. }, title={Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer}, journal={CANCER RESEARCH}, year=2005, pages={3707-3715} }